Semi-Supervised Learning Algorithm for Identifying High-Priority Drug–Drug Interactions Through Adverse Event Reports
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Identifying drug-drug interactions (DDIs) is a critical enabler for reducing adverse drug events and improving patient safety. Generating proper DDI alerts during prescribing workflow has the potential to prevent DDI-related adverse events. However, the implementation of DDI alerting system remains a challenge as users are experiencing alert overload which causes alert fatigue. One strategy to optimize the current system is to establish a list of high-priority DDIs for alerting purposes, though it is a resource-intensive task. In this study, we propose a machine learning framework to extract useful features from the FDA adverse event reports and then identify potential high-priority DDIs using an autoencoder-based semi-supervised learning algorithm. The experimental results demonstrate the effectiveness of using adverse event feature representations in differentiating high- and low-priority DDIs. Additionally, the proposed algorithm utilizes stacked autoencoders and weighted support vector machine for boosting classification performance, which outperforms other competing methods in terms of F-measure and AUC score. This framework integrates multiple information sources, leverages domain knowledge and clinical evidence, and provides a practical approach for pre-screening high-priority DDI candidates for medication alerts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adam: A Method for Stochastic Optimization
Kingma, D. P., & Ba, J. (2014) · arXiv · doi:10.48550/arxiv.1412.6980 · Cited by 98,946
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
Evaluation: from precision, recall and F-measure to ROC, informedness, markedness and correlation
Powers, D. M. W. (2020) · arXiv · doi:10.48550/arxiv.2010.16061 · Cited by 5,440
Mining association rules between sets of items in large databases
Agrawal, R., Imieliński, T., & Swami, A. (1993) · ACM SIGMOD Record · doi:10.1145/170036.170072 · Cited by 4,551
Andrzejak, R. G., Lehnertz, K., Mormann, F., Rieke, C., David, P., & Elger, C. E. (2001) · Physical Review E · doi:10.1103/physreve.64.061907 · Cited by 3,032 · cited 1×
“To show the effectiveness and scalability of our approach, we extended the experiments using a high-dimensional benchmark dataset - Epilepsy EEG dataset [52] - from the UCI”
MethodNuckols, T. K., Smith-Spangler, C., Morton, S. C., Asch, S. M., Patel, V. M., Anderson, L. J., Deichsel, E. L., & Shekelle, P. G. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-56 · Cited by 340 · cited 1×
“In general, DDI-related adverse drug events are largely preventable provided that proper warnings and interventions are implemented during provider’s prescribing workflow [3].”
BackgroundTiering Drug-Drug Interaction Alerts by Severity Increases Compliance Rates
Paterno, M. D., Maviglia, S. M., Gorman, P. N., Seger, D. L., Yoshida, E., Seger, A. C., Bates, D. W., & Gandhi, T. K. (2009) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m2808 · Cited by 263
Overrides of medication-related clinical decision support alerts in outpatients
Nanji, K. C., Slight, S. P., Seger, D. L., Cho, I., Fiskio, J. M., Redden, L. M., Volk, L. A., & Bates, D. W. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-001813 · Cited by 219
Tatonetti, N. P., Fernald, G. H., & Altman, R. B. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000214 · Cited by 203 · cited 2×
“the DDI evidence evaluation approaches [13], we focus on the adverse drug events and outcomes associated with the highand low-priority DDIs, aiming to identify useful features that help distinguish between these two DDI groups.”
BackgroundMethodHigh-priority drug–drug interactions for use in electronic health records
Phansalkar, S., Desai, A. A., Bell, D., Yoshida, E., Doole, J., Czochanski, M., Middleton, B., & Bates, D. W. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000612 · Cited by 134
Cited by
Deep learning in drug discovery: an integrative review and future challenges
Askr, H., Elgeldawi, E., Aboul Ella, H., Elshaier, Y. A. M. M., Gomaa, M. M., & Hassanien, A. E. (2023) · Artificial Intelligence Review · doi:10.1007/s10462-022-10306-1 · Cited by 390
Wubineh, B. Z., Deriba, F. G., & Woldeyohannis, M. M. (2024) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2023.11.019 · Cited by 141
Maassen, O., Fritsch, S., Palm, J., Deffge, S., Kunze, J., Marx, G., Riedel, M., Schuppert, A., & Bickenbach, J. (2021) · Journal of Medical Internet Research · doi:10.2196/26646 · Cited by 125
“3 Identification of drug interactions [65-67]”
Edrees, H., Amato, M. G., Wong, A., Seger, D. L., & Bates, D. W. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa034 · Cited by 64
Metadata
- Authors
- Liu, N., Chen, C.-B., & Kumara, S.
- Venue
- IEEE Journal of Biomedical and Health Informatics
- Published
- 2020-01
- Volume
- 24
- Issue
- 1
- Pages
- 57-68
- ISSN
- 2168-2194 (ISSN-L)
- 2168-2208
- OpenAlex
- W2965042294
- Cited by
- 50
- References
- 12
- FWCI
- 10.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Semi-Supervised Learning Algorithm for Identifying High-Priority Drug–Drug Interactions Through Adverse Event Reports. https://app.cochat.ai/papers/10.1109/jbhi.2019.2932740
- The paper
- Liu, N., Chen, C.-B., & Kumara, S. (2020). Semi-Supervised Learning Algorithm for Identifying High-Priority Drug–Drug Interactions Through Adverse Event Reports. IEEE Journal of Biomedical and Health Informatics. https://doi.org/10.1109/jbhi.2019.2932740
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.